GGrantIndex
Sort

146,196 grants matching diabetes

Targeting Schwann cell dysfunction and repair signaling in chemotherapy induced painful peripheral neuropathy

$2,833,086
Yi Ye · New York University · R01 · FY2024 · DE

National Eye Health Education Program (NEHEP)

$2,831,208
Adrienne Semidey · Quantum Research Corporation · N01 · FY2012 · OD

Metabolic Syndrome, Inflammation and Vascular Remodeling

$2,830,751
Francine K Welty · Beth Israel Deaconess Medical Center · P50 · FY2012 · HL

Psychosocial influences on appetite and eating behavior

$2,829,717
Bobby Cheon · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD

National Diabetes Education Program

$2,829,209
Lynne Doner Lotenberg · Hager Sharp · N01 · FY2014 · LM

Multi Site Randomized Trial of a GLP-1/GIP Receptor Agonist for Smoking Cessation

$2,828,440
Christian S Hendershot · University Of Southern California · U01 · FY2025 · DA

Sleep in Neurocognitive Aging and Alzheimers Research (SANAR)

$2,827,782
Alberto Rafael Ramos · University Of Miami School Of Medicine · R01 · FY2025 · AG

Next Generation Sequencing to Identify Genes for Type 2 Diabetes and Obesity

$2,827,204
Leslie J Baier · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK

UAB Precision Nutrition Clinical Center

$2,825,315
James O Hill · University Of Alabama At Birmingham · UG1 · FY2025 · HD

Estrogens, Cardiometabolic Health, and Female Cognitive Aging

$2,825,047
Jill M Daniel · Tulane University Of Louisiana · P01 · FY2025 · AG

Estrogens, Cardiometabolic Health, and Female Cognitive Aging

$2,822,728
Jill M Daniel · Tulane University Of Louisiana · P01 · FY2022 · AG

Genetic variant-based drug discovery targeting conserved pathways of aging

$2,822,483
Jan No Middle Name Vijg · Albert Einstein College Of Medicine · U19 · FY2023 · AG

Regulating NAD Metabolism to Inhibit Axon Degeneration in Neurodegenerative Diseases

$2,820,477
Jeffrey D Milbrandt · Washington University · RF1 · FY2017 · AG

Expanding Excellence in Developmental Biology in Oklahoma

$2,820,000
Linda F. Thompson · Oklahoma Medical Research Foundation · P20 · FY2013 · GM

UAB Precision Nutrition Clinical Center

$2,818,991
James O Hill · University Of Alabama At Birmingham · UG1 · FY2024 · HD

Pharmacogenomics of Membrane Transporters

$2,818,177
Kathleen M Giacomini · University Of California, San Francisco · U19 · FY2011 · GM

Coronary Revascularization in Diabetic Patients

$2,817,871
Valentin Fuster · Icahn School Of Medicine At Mount Sinai · U01 · FY2008 · HL

Etiology of Geographic and Racial Differences in Stroke

$2,816,745
George Howard · University Of Alabama At Birmingham · U01 · FY2007 · NS

Comparative Effectiveness of Health System vs. Multilevel Interventions to Reduce Hypertension Disparities

$2,814,626
Lisa A Cooper · Johns Hopkins University · UH3 · FY2016 · HL

National Center for Engagement in Diabetes Equity Research: National CEDER

$2,813,862
Nadia S Islam · New York University School Of Medicine · U2C · FY2023 · DK

RESETTING HYPOTHALAMIC AND AUTONOMIC NEUROCIRCUITRY TO TREAT DIABETES

$2,813,410
University Of Washington · · FY2021 · Defense Health Agency

Transplant Tolerance in Non-Human Primates

$2,812,559
Christian P Larsen · Emory University · U19 · FY2008 · AI

Safe Cardiometabolic Drug Prescribing to Prevent Injury in Nursing Home Residents

$2,812,212
Sarah Dyer Berry · Hebrew Rehabilitation Center For Aged · RF1 · FY2019 · AG

Architecture and control of exocytosis and endocytosis in excitable cells

$2,811,077
Justin Taraska · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL

Early Vascular Contributions to Dementia Risk in African-Americans

$2,810,076
Rachel A Whitmer · University Of California At Davis · RF1 · FY2017 · AG